HDT Bio’s vision: mRNA has already proved its worth in the fight against infectious diseases. Now Seattle-based HDT Bio is working on a next-generation RNA technology to fight cancer and infectious disease that it said is cheaper, easier to manufacture and transport and even safer than current mRNA vaccines. HDT Bio’s AMPLIFY vaccine platform combines self-amplifying […]

The maker of a diabetes-focused digital health app has published new data showing its product can lead to clinically meaningful improvement in HbA1c for people with severe diabetes. The data highlight the potential of digital health solutions, but it also shows that traditional pharmaceutical firms are wading into the digital health future. Earlier this summer, […]

Pear Therapeutics was once regarded as a digital therapeutics pioneer, but its spiral into bankruptcy has the industry searching for the best path forward. While some favor going direct to consumers, others say the solution is in generating more robust clinical trial data to persuade hesitant payers. The most common and easiest way to take […]